dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Giuliani, Rosa |
dc.contributor.author | Tabernero Caturla, Josep |
dc.contributor.author | Cardoso, Fatima |
dc.contributor.author | McGregor, Keith Hanson |
dc.contributor.author | Vyas, Malvika |
dc.contributor.author | de Vries, Elisabeth |
dc.date.accessioned | 2021-03-16T09:42:14Z |
dc.date.available | 2021-03-16T09:42:14Z |
dc.date.issued | 2019-03-06 |
dc.identifier.citation | Giuliani R, Tabernero J, Cardoso F, McGregor KH, Vyas M, De Vries EGE. Knowledge and use of biosimilars in oncology: A survey by the European Society for Medical Oncology. ESMO Open. 2019 Mar 6;4(2):e000460. |
dc.identifier.issn | 2059-7029 |
dc.identifier.uri | https://hdl.handle.net/11351/5760 |
dc.description | Biosimilars; Oncologia; Prescriptors |
dc.language.iso | eng |
dc.publisher | BMJ |
dc.relation.ispartofseries | ESMO Open;4(2) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Oncologia |
dc.subject | Medicaments antineoplàstics |
dc.subject | Càncer - Tractament |
dc.subject.mesh | Medical Oncology |
dc.subject.mesh | Biosimilar Pharmaceuticals |
dc.subject.mesh | Neoplasms |
dc.subject.mesh | /therapy |
dc.title | Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1136/esmoopen-2018-000460 |
dc.subject.decs | oncología médica |
dc.subject.decs | fármacos biosimilares |
dc.subject.decs | neoplasias |
dc.subject.decs | /terapia |
dc.relation.publishversion | https://www.esmoopen.com/article/S2059-7029(20)30171-X/fulltext |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Giuliani R] Medical Oncology, San Camillo-Forlanini Hospital, Rome, Italy. [Tabernero J] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Cardoso F] Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. [McGregor KH] Chief Executive Officer, European Society for Medical Oncology (ESMO), Lugano, Switzerland. [Vyas M] Head of Public Policy, European Society for Medical Oncology, Lugano, Switzerland. [de Vries EGE] Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands |
dc.identifier.pmid | 30962961 |
dc.identifier.wos | 000468581300007 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |